Market Cap (In USD)
19.8 Million
Revenue (In USD)
2340.00
Net Income (In USD)
-116.89 Thousand
Avg. Volume
343.00
- Currency
- USD
- Country
- Consumer Defensive
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0586-0.3275
- PE
- -
- EPS
- -
- Beta Value
- 2.765
- ISIN
- US38138N1046
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Mr. Shuang Liu
- Employee Count
- -
- Website
- https://www.goldenwellbiotech.com
- Ipo Date
- 2022-09-30
- Details
- Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company is developing five products, including JI MAIbovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG 3D active collagen peptide, as well as DNA repair tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.
More Stocks
-
AFSIM
-
RAMP
-
0050
-
OESX
-
WHA-R
-
AH
-
SMLISUZUSML Isuzu Limited
SMLISUZU
-
VKSC